Tone mix
Week by week 52 weeks
Share of Teva Pharmaceutical Industries Limited's 235 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Apr 27, 2026 · tone +99Teva Pharmaceutical (TEVA): David Einhorn Likes This Pharma Stock+79
- Week of Aug 10, 2026 · tone +100Teva Pharmaceutical Industries Ltd: Moody's Ratings Upgrades Teva to Investment Grade, Reflecting the Ongoing Execution of Pivot to Growth Strategy+66
- Week of Mar 30, 2026 · tone +100Teva Pharmaceutical Industries Ltd: Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair (omalizumab)+64
- Week of Jun 8, 2026 · tone +98Teva Pharmaceutical Industries Ltd: Teva Closes Acquisition of Emalex Biosciences, Strengthening Late-Stage Neuroscience Pipeline and Advancing Pivot to Growth Strategy+63
- Week of Aug 17, 2026 · tone +100Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Receives Average Recommendation of "Moderate Buy" from Brokerages+57
- Week of Oct 26, 2026 · tone +99Teva Pharmaceutical Industries Ltd: Teva Acquires Worldwide Rights to BXCL501, Further Expanding Innovative Neuroscience Pipeline+55
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Teva Pharmaceutical Industries Limited in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 8 | +62 |
| Last 30 sessions | 25 | +51 |
| Last 90 sessions | 66 | +45 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Friday, November 6, 2026
2 headlines, average tone +100: 2 positive, 0 neutral and 0 negative. Showing all 2.
- www.tickerreport.com · 1 outletLeerink Partners Issues Positive Forecast for Teva Pharmaceutical Industries (NYSE:TEVA) Stock PricePositive
- www.insidermonkey.com · 1 outletTeva Pharmaceutical Industries Limited's (TEVA) Innovative Brands Drive Stronger GrowthPositive
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Leerink Partners Issues Positive Forecast for Teva Pharmaceutical Industries (NYSE:TEVA) Stock Price | www.tickerreport.com | 1 | Positive |
| Teva Pharmaceutical Industries Limited's (TEVA) Innovative Brands Drive Stronger Growth | www.insidermonkey.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, November 5, 2026
2 headlines, average tone +100: 2 positive, 0 neutral and 0 negative. Showing all 2.
- www.tickerreport.com · 1 outletTeva Pharmaceutical Industries (NYSE:TEVA) Stock Rated Buy in New Coverage at HC WainwrightPositive
- www.tickerreport.com · 1 outletTeva Pharmaceutical Industries (NYSE:TEVA) Releases Quarterly Earnings Results, Beats Expectations By $0.14 EPSPositive
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Teva Pharmaceutical Industries (NYSE:TEVA) Stock Rated Buy in New Coverage at HC Wainwright | www.tickerreport.com | 1 | Positive |
| Teva Pharmaceutical Industries (NYSE:TEVA) Releases Quarterly Earnings Results, Beats Expectations By $0.14 EPS | www.tickerreport.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, November 4, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.fool.com · 1 outletTeva (TEVA) Q3 2026 Earnings Call TranscriptNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Teva (TEVA) Q3 2026 Earnings Call Transcript | www.fool.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, November 3, 2026
3 headlines, average tone +33: 2 positive, 0 neutral and 1 negative. Showing all 3.
- www.rttnews.com · 1 outletTeva Pharmaceutical Industries Limited Q3 Income DeclinesNegative
- www.finanznachrichten.de · 1 outletTeva Pharmaceutical Industries Ltd: Teva's Pivot to Growth Strategy Delivers 33% Growth Across Key Innovative Brands; Raises 2026 Outlook for AUSTEDO, AJOVY and UZEDY; Delivers Substantial Gross Margin ExpansionPositive
- www.finanznachrichten.de · 1 outletTeva Pharmaceutical Industries Ltd: Teva and Samsung Bioepis Announce Agreement to Commercialize Two FDA-Approved Biosimilars in the U.S.Positive
Show the table · 3 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Teva Pharmaceutical Industries Limited Q3 Income Declines | www.rttnews.com | 1 | Negative |
| Teva Pharmaceutical Industries Ltd: Teva's Pivot to Growth Strategy Delivers 33% Growth Across Key Innovative Brands; Raises 2026 Outlook for AUSTEDO, AJOVY and UZEDY; Delivers Substantial Gross Margin Expansion | www.finanznachrichten.de | 1 | Positive |
| Teva Pharmaceutical Industries Ltd: Teva and Samsung Bioepis Announce Agreement to Commercialize Two FDA-Approved Biosimilars in the U.S. | www.finanznachrichten.de | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 27, 2026
1 headline, average tone +99: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.finanznachrichten.de · 1 outletTeva Pharmaceutical Industries Ltd: Teva Acquires Worldwide Rights to BXCL501, Further Expanding Innovative Neuroscience PipelinePositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Teva Pharmaceutical Industries Ltd: Teva Acquires Worldwide Rights to BXCL501, Further Expanding Innovative Neuroscience Pipeline | www.finanznachrichten.de | 1 | Positive |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Teva Pharmaceutical Industries Limited, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.